Trial Outcomes & Findings for Risk Markers in the Acute Coronary Syndromes (NCT NCT00521976)
NCT ID: NCT00521976
Last Updated: 2021-09-29
Results Overview
Recruitment status
COMPLETED
Target enrollment
871 participants
Primary outcome timeframe
24 months.
Results posted on
2021-09-29
Participant Flow
Consecutive recruitment at Stavanger University Hospital.
Participant milestones
| Measure |
Group 1
Men and women admitted with chest pain and a suspicious acute coronary syndrome (ACS)
|
|---|---|
|
Overall Study
STARTED
|
871
|
|
Overall Study
COMPLETED
|
871
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Risk Markers in the Acute Coronary Syndromes
Baseline characteristics by cohort
| Measure |
Group 1
n=871 Participants
Men and women admitted with chest pain and a suspicious acute coronary syndrome (ACS)
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
300 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
571 Participants
n=5 Participants
|
|
Age, Continuous
|
69.6 years
STANDARD_DEVIATION 14.4 • n=5 Participants
|
|
Sex: Female, Male
Female
|
340 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
531 Participants
n=5 Participants
|
|
Region of Enrollment
Norway
|
871 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 24 months.Outcome measures
| Measure |
Group 1
n=871 Participants
Men and women admitted with chest pain and a suspicious acute coronary syndrome (ACS)
|
|---|---|
|
Total Mortality.
|
138 Participants.
|
SECONDARY outcome
Timeframe: 24 months.Recurrent Troponin-T (TnT) positive events; Symptoms of coronary ischemia associated with TnT \>0.05 ng/mL with a pattern of gradual rise and fall in TnT
Outcome measures
| Measure |
Group 1
n=871 Participants
Men and women admitted with chest pain and a suspicious acute coronary syndrome (ACS)
|
|---|---|
|
Recurrent Troponin-T (TnT) Positive Events
|
155 Participants
|
Adverse Events
Group 1
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dennis W.T. Nilsen MD PhD FESC FAHA
Stavanger University Hospital
Phone: +4705151
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60